Price
chg
chg neg
quotes and stock data may be delayed 15 minutes
My Notes
Only BPIQ Pro members can create company notes. Learn more here.
52 wk low
low api
52 wk hi
high api
Cash
Burn Rate (Qtr)
Mkt Cap
mkt cap api
Avg Volume
volume api
*cash/burn updated:
Drug Pipeline
Click the button to see the updated pipeline
No drug found
We don't have any drug data for this company yet
Drug | Disease (links)
Stage (next event)
Catalyst Date
Loading Catalysts...
search in progress
Pipeline powered by
LXEO
Company Profile
Lexeo Therapeutics is a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to high-impact genetic medicine candidates for cardiovascular diseases and APOE4-associated Alzheimer's disease. The company boasts a comprehensive pipeline of investigational AAV-mediated gene therapies in genetic cardiovascular conditions and genetic conditions of the CNS.
Recent Posts
See what the community is saying - click to see full post.